Genomma Lab Internacional Sab De Cv operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genomma Lab Internacional Sab De Cv with three other
pharmaceutical manufacturers in Latin America:
sales of 2.10 billion Brazilian Reals [US$663.76 million]
of which 83%
was Diagnostic Medicine),
Diagnosticos Da America SA
(3.04 billion Brazilian Reals [US$962.89 million]
of which 100%
was servi os auxiliares), and
Instituto Hermes Pardini SA
based in Brazil
(899.41 million Brazilian Reals [US$284.81 million]
of which 60%
was Reference Labs).
During the year ended December of 2016, sales at
Genomma Lab Internacional Sab De Cv were 11.32 billion Mexican Pesos (US$602.82 million).
increase of 2.5%
versus 2015, when the company's sales were 11.04 billion Mexican Pesos.
Despite this increase, sales are still
below the level achieved in 2014, when Genomma Lab Internacional Sab De Cv
reported sales of 11.54 billion Mexican Pesos.
Sales of Mexico - Operating saw an increase
that was more than double the company's growth rate: sales were up
19.7% in 2016, from
3.92 billion Mexican Pesos to 4.69 billion Mexican Pesos.
Not all segments of Genomma Lab Internacional Sab De Cv experienced an increase in sales in 2016:
sales of International fell 7.0% to 6.63 billion Mexican Pesos.